A Study to Learn More About How Drug Aflibercept Works in Canadian Patients With Reduced Vision Caused by New Blood Vessels Growing in the Eye (Myopic Choroidal Neovascularization or mCNV)

NCT04524910 · clinicaltrials.gov ↗

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Myopic Choroidal Neovascularization

Interventions

DRUG: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

Sponsor

Bayer